يعرض 1 - 10 نتائج من 41 نتيجة بحث عن '"Méndez-Vidal, M J"', وقت الاستعلام: 1.49s تنقيح النتائج
  1. 1
    دورية أكاديمية

    مصطلحات موضوعية: Androgen, Castration, Molecular, Biomarkers, Research

    وصف الملف: application/pdf

    العلاقة: Clinical & Translational Oncology; Vol. 23 (february 2021), p. 969-979; https://ddd.uab.cat/record/240159Test; urn:10.1007/s12094-021-02561-5; urn:oai:ddd.uab.cat:240159; urn:pmcid:PMC8057980; urn:pmc-uid:8057980; urn:pmid:33625671; urn:articleid:16993055v23p969; urn:oai:pubmedcentral.nih.gov:8057980

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية

    المساهمون: Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain

    العلاقة: https://dx.doi.org/10.1200/jco.22.01414Test; Suárez C, Larkin JMG, Patel P, Valderrama BP, Rodriguez-Vida A, Glen H, et al. Phase II Study Investigating the Safety and Efficacy of Savolitinib and Durvalumab in Metastatic Papillary Renal Cancer (CALYPSO). Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 Feb 21:JCO2201414. PubMed PMID: 36809050. Epub 2023/02/23. eng.; http://hdl.handle.net/10541/626078Test; Journal of Clinical Oncology

  6. 6
  7. 7
    دورية أكاديمية

    المساهمون: Conteduca, V, Wetterskog, D, Sharabiani, M. T. A, Grande, Elisabetta, Fernandez Perez, M. P, Jayaram, A, Salvi, S, Castellano, D, Romanel, Alessandro, Lolli, C, Casadio, V, Gurioli, G, Amadori, D, Font, A, Vazquez Estevez, S, González Del Alba, A, Mellado, B, Fernandez Calvo, O, Méndez Vidal, M. J, Climent, M. A, Duran, I, Gallardo, E, Rodriguez, A, Santander, C, Sáez, M. I, Puente, J, Gasi Tandefelt, D, Wingate, A, Dearnaley, D, Demichelis, Francesca, De Giorgi, U, Gonzalez Billalabeitia, E, Attard, G.

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28472366; info:eu-repo/semantics/altIdentifier/wos/WOS:000404134100016; volume:2017; numberofpages:9; journal:ANNALS OF ONCOLOGY; http://hdl.handle.net/11572/175739Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85019315640

  8. 8
    مؤتمر

    المساهمون: Barts ECMC, Barts Cancer Institute, Queen Mary University of London, London

    العلاقة: https://dx.doi.org/10.1200/JCO.2022.40.17_suppl.LBA4503Test; Powles T, Mendez-Vidal MJ, Rodriguez-Vida A, Perez-Valderrama B, Esteban E, Thistlethwaite F, et al. CALYPSO: A three-arm randomized phase II study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer. Journal of Clinical Oncology. 2022 Jun;40(17). PubMed PMID: WOS:000891791500023.; http://hdl.handle.net/10541/626047Test; Journal of Clinical Oncology

  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية

    مصطلحات موضوعية: C-myc, Clear-cell renal cell carcinoma, HIF, Sunitinib

    وصف الملف: application/pdf

    العلاقة: OncoTargets and therapy; Vol. 10 (september 2017), p. 4635-4643; https://ddd.uab.cat/record/186348Test; urn:10.2147/OTT.S137677; urn:oai:ddd.uab.cat:186348; urn:pmid:29033582; urn:pmcid:PMC5614781; urn:pmc-uid:5614781; urn:articleid:11786930v10p4635; urn:oai:egreta.uab.cat:publications/b071e415-bafb-47c1-a8fb-3b58f22fe52e; urn:scopus_id:85030245220; urn:oai:pubmedcentral.nih.gov:5614781